Azurity - PharmaKB

Azurity

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Bidil	Hydralazine, Isosorbide	2005-06-23		Heart failure , Pulmonary hypertension , Malignant hypertension , Hypertension , Nephrotic syndrome , Edema , Dyskinesias , Schizophrenia , Coronary disease , Angina pectoris , Gastroesophageal reflux , Diffuse esophageal spasm , Poisoning , Cyanosis
Edarbi	Azilsartan kamedoxomil	2011-02-25	2025-2031	Hypertension , Heart failure , Glomerulonephritis , Liver cirrhosis , Nephrotic syndrome , Edema
Edarbyclor	Azilsartan kamedoxomil, Chlorthalidone	2011-12-20	2025-2031	Hypertension , Heart failure , Glomerulonephritis , Liver cirrhosis , Nephrotic syndrome , Edema
Epaned	Enalapril	2013-08-13	2032-2036	Heart failure, Diabetic nephropathies, Left ventricular dysfunction, Rheumatoid arthritis, Edema, Malignant hypertension, Bartter syndrome, Hypertension, Nephrotic syndrome, Variant angina pectoris, Atrial fibrillation, Myocardial infarction, Atrial flutter, Supraventricular tachycardia
Eprontia	Topiramate	2021-11-05	2027-2040	Pain, Epilepsy, Lennox gastaut syndrome, Infantile spasms, Partial epilepsies, Tonic-clonic epilepsy, Bipolar disorder, Obesity
Eryped	Erythromycin	1982-01-01		Acne vulgaris, Bacterial infections, Gonorrhea, Campylobacter infections, Whooping cough, Chlamydia infections, Streptococcal infections, Legionnaires' disease, Urethritis, Bacterial eye infections, Syphilis, Staphylococcal infections, Mycoplasma infections, Protozoan infections, Gastroenteritis, Chancroid, Erythrasma, Rosacea
Evekeo	Amphetamine	2012-08-09	2024-2038	Narcolepsy, Attention deficit disorder with hyperactivity
Firvanq	Vancomycin	2018-01-26	2035	Neutropenia, Postoperative complications, Diarrhea, Bacterial infections, Staphylococcal infections, Bacterial endocarditis, Pneumococcal meningitis, Pseudomembranous enterocolitis
Fleqsuvy	Baclofen	2022-02-04	2037-2041	Multiple sclerosis, Spinal cord injuries, Spinal cord neoplasms, Hiccup, Neurogenic urinary bladder, Muscle spasticity, Cerebral palsy, Spinal cord ischemia, Trigeminal neuralgia, Huntington disease, Transverse myelitis, Spondylolysis, Intractable pain
Gliadel	Carmustine	1996-09-23		Carcinoma, Brain neoplasms, Non-hodgkin lymphoma, Lung neoplasms, Multiple myeloma, Glioblastoma, Hodgkin disease, Melanoma, Medulloblastoma, Colonic neoplasms, Ependymoma
Horizant	Gabapentin enacarbil	2011-04-06	2025-2029	Epilepsy, Postherpetic neuralgia, Partial epilepsies, Bipolar disorder, Phobic disorders
Katerzia	Amlodipine	2019-07-08	2029-2041	Heart failure, Diabetic nephropathies, Hypertension, Left ventricular dysfunction, Coronary artery disease, Variant angina pectoris, Nephrotic syndrome, Edema
Konvomep	Omeprazole	2022-08-30	2025-2042	Gastroesophageal reflux, Helicobacter infections, Stomach ulcer, Duodenal ulcer, Zollinger-ellison syndrome, Esophagitis, Heartburn, Rheumatoid arthritis, Pain, Fever, Inflammation, Osteoarthritis, Rheumatic fever, Gout, Urinary tract infections, Sinusitis, Nontuberculous mycobacterium infections, Otitis media, Bacterial infections, Infectious skin diseases, Bacterial skin diseases, Soft tissue infections, Mycoplasma pneumonia, Chlamydia infections, Bronchitis, Streptococcal infections, Tonsillitis, Lyme disease, Staphylococcal infections, Listeriosis, Haemophilus infections, Protozoan infections, Human bites, Actinomycosis, Pulmonary tuberculosis, Mycobacterium avium-intracellulare infection, Mycobacterium infections

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication